Dr. Jeff Ratliff talks with Dr. Gabriela Figueiredo Pucci about how participation in a social media community influenced PIF and career development among neurology trainees.

Read the related article in Neurology® Education.

Disclosures can be found at Neurology.org.

Dr. Stacey Clardy talks with Dr. John Ney about wait times for new neurology office visits among commercially insured persons in the United States.

Read the related article in Neurology®.

Disclosures can be found at Neurology.org.

Dr. Dan Ackerman talks with Dr. Reza Bavarsad Shahripour about the diagnostic performance of 4 major modalities: TCD, TTE, TEE, and cardiac CT in patients with embolic stroke of undetermined source.

Read the related article in Neurology® Clinical Practice.

Disclosures can be found at Neurology.org.

Dr. Shuvro Roy talks with Dr. Amanda L. Piquet about the efficacy and safety of miv-cel in patients with stiff person syndrome.

Read more about this abstract on the AAN website.

Disclosures can be found at Neurology.org.

In part two of this series, Dr. Andy Southerland talks with Dr. Dan Ackerman about a few rapid‑fire concepts from the 2026 guidelines, focusing on what is new and how emerging data may shape patient care.

Disclosures can be found at Neurology.org.

In part one of this series, Dr. Andy Southerland talks with Dr. Dan Ackerman about the latest guidelines for managing acute ischemic stroke, emphasizing thrombolytic therapy, imaging techniques, and decision-making regarding treatment in extended time windows.

Disclosures can be found at Neurology.org.

The June 2026 Recall highlights four previously posted episodes on parkinsonian disorders. The episode begins with Dr. Valtteri Kaasinen discussing the clinical challenges of diagnosing Parkinson disease and how that diagnosis can evolve over time. The discussion continues with Dr. YuHong Fu, who addresses the importance of differentiating between dementia with Lewy bodies and Parkinson disease dementia. The third episode features Dr. Daniel Weintraub discussing clinical considerations and strategies for effective communication when addressing cognitive concerns in patients with Parkinson disease. The episode concludes with Prof. Franziska Hopfner discussing the frequency and disease trajectory of MSA patients who do not experience dysautonomia, compared with those who have autonomic involvement.

Podcast links:

Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years

Dementia with Lewy Bodies and Parkinson Disease Dementia

Clinical Approach to Dementia Risk in Patients with Parkinson Disease

Multiple System Atrophy Without Dysautonomia

Article links:

Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years

Dementia with Lewy bodies and Parkinson Disease Dementia — The Same or Different and is it Important?

Long-Term Dementia Risk in Parkinson Disease

Multiple System Atrophy Without Dysautonomia: An Autopsy-Confirmed Study

Disclosures can be found at Neurology.org.

Dr. Gregg Day talks with Drs. Sonia Vallabh and Eric Minikel about scientific insights and the future of prion disease treatment, highlighting the importance of early diagnosis, personalized medicine, and hope for affected families.

Learn about the clinical trial.

Learn more about the Prion Alliance.

Disclosures can be found at Neurology.org.